Product Images Nitroglycerin

This is a product description for Nitroglycerin Sublingual Tablets, USP, 0.3 mg/tablet manufactured by Glenmark Pharmaceuticals. The tablets are to be dispensed by pharmacists with patient information provided separately for each patient. Each tablet contains 0.3 mg nitroglycerin, and usual dosage information is provided in the prescribing information. The tablets should be stored at room temperature, kept in the original, unopened container, and kept out of reach of children. It is warned that a 'burning or tingling' sensation may be felt at the site of tablet placement, but the lack of such sensations doesn't indicate failure of nitroglycerin release. Medical attention is recommended if the pain persists after three tablets within a 15-minute period or is different from usual. It is also advised to keep the tablets in the original container or a supplemental nitroglycerin container labeled suitable for nitroglycerin sublingual tablets as to not lose potency, and the tablets should not be crushed, chewed or swallowed. Lot and expiry information can be found in the unvarnished area.*

This is a description of Nitroglycerin Sublingual Tablets, USP. The tablets come in a 0.4mg size and are meant to be dissolved under the tongue. There are 100 tablets per container, and the medication is dispensed by prescription only. The tablets should be stored at between 20-25 degrees Celsius, and dispensed in the original, unopened container. If the pain persists after three tablets have been taken in a 15-minute period or if the pain is different than what is typically experienced, medical attention is recommended. Users may feel a burning or tingling sensation where the tablet is placed, and the user should not swallow the tablets. The medication is manufactured by Glenmark Pharmaceuticals in India and distributed in the USA.*

This is a product description for Nitroglycerin Sublingual Tablets, USP with a strength of 0.6 mg per tablet, manufactured by Glenmark Pharmaceuticals. It includes instructions for use, usual dosage, and storage information. The tablets are dispensed by a pharmacist and the patient information is provided separately. It also warns users not to crush, chew, or swallow the tablets and to store them in an appropriate container to prevent loss of potency. Contact information for Glenmark Pharmaceuticals is also provided.*